Overview

Pharmacokinetics of MB-102 and Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types

Status:
Completed
Trial end date:
2021-08-04
Target enrollment:
Participant gender:
Summary
This study is a pilot, safety, and pharmacokinetic study of MB-102 versus iohexol and the use of the non-invasive optical renal function monitor (ORFM) device in normal and compromised renal function participants with different skin color types.
Phase:
Phase 2
Details
Lead Sponsor:
MediBeacon